PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology

This paper describes a novel methodology, PRO_SELECT, which combines elements of structure-based drug design and combinatorial chemistry to create a new paradigm for accelerated lead discovery. Starting with a synthetically accessible template positioned in the active site of the target of interest, PRO_SELECT employs database searching to generate lists of potential substituents for each substituent position on the template. These substituents are selected on the basis of their being able to couple to the template using known synthetic routes and their possession of the correct functionality to interact with specified residues in the active site. The lists of potential substituents are then screened computationally against the active site using rapid algorithms. An empirical scoring function, correlated to binding free energy, is used to rank the substituents at each position. The highest scoring substituents at each position can then be examined using a variety of techniques and a final selection is made. Combinatorial enumeration of the final lists generates a library of synthetically accessible molecules, which may then be prioritised for synthesis and assay. The results obtained using PRO_SELECT to design thrombin inhibitors are briefly discussed.

[1]  Edward P. Jaeger,et al.  Application of Genetic Algorithms to Combinatorial Synthesis: A Computational Approach to Lead Identification and Lead Optimization†,∇ , 1996 .

[2]  PatrickY.-S. Lam,et al.  Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.

[3]  Klaus Gubernator,et al.  Optimization of the Biological Activity of Combinatorial Compound Libraries by a Genetic Algorithm , 1995 .

[4]  Barry A. Bunin,et al.  A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives , 1992 .

[5]  Arup K. Ghose,et al.  Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics , 1989, J. Chem. Inf. Comput. Sci..

[6]  J. Bieth,et al.  In vivo significance of kinetic constants of protein proteinase inhibitors. , 1984, Biochemical medicine.

[7]  Gareth Jones,et al.  Pharmacophoric pattern matching in files of three-dimensional chemical structures: Comparison of conformational-searching algorithms for flexible searching , 1994, J. Chem. Inf. Comput. Sci..

[8]  P. Willett,et al.  Implementation of nonhierarchic cluster analysis methods in chemical information structure search , 1986 .

[9]  S. P. Fodor,et al.  Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. , 1994, Journal of medicinal chemistry.

[10]  M. J. Gardner,et al.  COMBINATORIAL SYNTHESIS : THE DESIGN OF COMPOUND LIBRARIES AND THEIR APPLICATION TO DRUG DISCOVERY , 1995 .

[11]  N. W. Murrall,et al.  How accurate does a force field need to be? , 1989, Comput. Chem..

[12]  N. Cohen,et al.  The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. , 1993, Journal of medicinal chemistry.

[13]  C Baboonian,et al.  Proteinase Inhibitors , 2020, Bayer-Symposium.

[14]  John M. Barnard,et al.  Clustering of chemical structures on the basis of two-dimensional similarity measures , 1992, J. Chem. Inf. Comput. Sci..

[15]  Ajay,et al.  Computational methods to predict binding free energy in ligand-receptor complexes. , 1995, Journal of medicinal chemistry.

[16]  J J Baldwin,et al.  Application of the three-dimensional structures of protein target molecules in structure-based drug design. , 1994, Journal of medicinal chemistry.

[17]  T L Blundell,et al.  Protein structure--based drug design. , 1994, Annual review of biophysics and biomolecular structure.

[18]  Regine Bohacek,et al.  Multiple Highly Diverse Structures Complementary to Enzyme Binding Sites: Results of Extensive Application of a de Novo Design Method Incorporating Combinatorial Growth , 1994 .

[19]  Conrad C. Huang,et al.  Automated site-directed drug design using molecular lattices , 1992 .

[20]  I. Kuntz,et al.  Structure-Based Molecular Design , 1994 .

[21]  R C Wade,et al.  Rational modification of human synovial fluid phospholipase A2 inhibitors. , 1994, Journal of medicinal chemistry.

[22]  P. Willett,et al.  A Fast Algorithm For Selecting Sets Of Dissimilar Molecules From Large Chemical Databases , 1995 .

[23]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[24]  S. P. Fodor,et al.  Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. , 1994, Journal of medicinal chemistry.

[25]  Arthur Dalby,et al.  Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited , 1992, J. Chem. Inf. Comput. Sci..

[26]  Yvonne C. Martin,et al.  Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..

[27]  R. Ritzmann,et al.  Dissociation of alcohol tolerance and dependence , 1976, Nature.

[28]  Valerie J. Gillet,et al.  SPROUT: A program for structure generation , 1993, J. Comput. Aided Mol. Des..

[29]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[30]  H. Anderson,et al.  Thrombolysis in acute myocardial infarction. , 1993, The New England journal of medicine.

[31]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[32]  Barry Robson,et al.  PRO_LIGAND: An approach to de novo molecular design. 3. A genetic algorithm for structure refinement , 1995, J. Comput. Aided Mol. Des..

[33]  Andrew R. Leach,et al.  Automated molecular design: A new fragment-joining algorithm , 1994, J. Comput. Aided Mol. Des..

[34]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[35]  David E. Clark,et al.  PRO_LIGAND: An Approach to de Novo Molecular Design, 5. Tools for the Analysis of Generated Structures , 1995, J. Chem. Inf. Comput. Sci..

[36]  D. Matthews,et al.  Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones. , 1993, Journal of medicinal chemistry.

[37]  M. Hahn.  Receptor surface models. 1. Definition and construction. , 1995, Journal of medicinal chemistry.

[38]  D K Gehlhaar,et al.  De novo design of enzyme inhibitors by Monte Carlo ligand generation. , 1995, Journal of medicinal chemistry.

[39]  D. Kempf,et al.  Synthetic chemical diversity: solid phase synthesis of libraries of C2 symmetric inhibitors of HIV protease containing diamino diol and diamino alcohol cores. , 1995, Journal of medicinal chemistry.

[40]  M. Murcko,et al.  GroupBuild: a fragment-based method for de novo drug design. , 1993, Journal of medicinal chemistry.

[41]  Garland R. Marshall,et al.  VALIDATE: A New Method for the Receptor-Based Prediction of Binding Affinities of Novel Ligands , 1996 .

[42]  Robert P. Sheridan,et al.  Using a Genetic Algorithm To Suggest Combinatorial Libraries , 1995, J. Chem. Inf. Comput. Sci..

[43]  J. Scott Dixon,et al.  A good ligand is hard to find: Automated docking methods , 1993 .

[44]  Tad Hurst,et al.  Flexible 3D searching: The directed tweak technique , 1994, J. Chem. Inf. Comput. Sci..

[45]  M. Karplus,et al.  Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase. , 1993, Journal of medicinal chemistry.

[46]  D C Spellmeyer,et al.  Measuring diversity: experimental design of combinatorial libraries for drug discovery. , 1995, Journal of medicinal chemistry.

[47]  Dinesh V. Patel,et al.  Strategy and Tactics in Combinatorial Organic Synthesis. Applications to Drug Discovery , 1996 .

[48]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[49]  D C Spellmeyer,et al.  Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. , 1994, Journal of medicinal chemistry.

[50]  Owen Johnson,et al.  The development of versions 3 and 4 of the Cambridge Structural Database System , 1991, J. Chem. Inf. Comput. Sci..

[51]  Mark A. Gallop,et al.  Combinatorial Organic Synthesis of Highly Functionalized Pyrrolidines: Identification of a Potent Angiotensin Converting Enzyme Inhibitor from a Mercaptoacyl Proline Library , 1995 .

[52]  D. E. Clark,et al.  PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores. , 1994, Journal of medicinal chemistry.

[53]  G. Klebe.  The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. , 1994, Journal of molecular biology.

[54]  Akiko Itai,et al.  Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation , 1991 .

[55]  Johann Gasteiger,et al.  Assessing Similarity and Diversity of Combinatorial Libraries by Spatial Autocorrelation Functions and Neural Networks , 1996 .

[56]  W. Guida,et al.  Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine. , 1993, Journal of medicinal chemistry.

[57]  J. Mason,et al.  New perspectives in lead generation II: Evaluating molecular diversity , 1996 .

[58]  P Willett,et al.  Pharmacophoric pattern matching in files of three-dimensional chemical structures: use of bounded distance matrices for the representation and searching of conformationally flexible molecules. , 1992, Journal of molecular graphics.